$4.39
▼ -0.2% Today
as of Sep 4, 16:51 ET
Last 30 days
Recent Press Releases & News
Is MacroGenics (MGNX) Stock Outpacing Its Medical Peers This Year?
B. Riley Raises Price Target on MacroGenics to $11 From $9, Keeps Buy Rating
Can MacroGenics (MGNX) Turn Gilead Sciences (GILD)’s $10M Milestone Into a Major Pipeline Catalyst?
Overview
52-week range
$1.29
$5.08
82% of range
Avg surprise (last 3)
-1.6%
Avg reaction (last 2)
-2.6%
0% positive
Latest IV / EM
168%
EM ±26.2% · $4 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $0.31 | — | — | — | — | financials |
| Wed May 13, 2026 | Mar/2026 | $-0.58 | $-0.57 | -1.8% | +10.8% | -2.0% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $0.27 | — | — | — | — | financials |
| Thu Aug 14, 2025 | Jun/2025 | $-0.57 | $-0.59 | +3.4% | — | — | earnings |
| Tue May 13, 2025 | Mar/2025 | $-0.65 | $-0.61 | -6.6% | — | -3.1% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $0.90 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.89 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.84 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $0.28 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $0.92 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.61 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $33M | $21M | — | $73M | $7M | $13M | — | $111M |
| Cost of revenue | — | — | — | $0 | $0 | $0 | — | $168,000 |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-14M | $-33M | — | $19M | $-43M | $-43M | — | $54M |
| Net income | $20M | $-37M | — | $17M | $-36M | $-41M | — | $56M |
| EPS (diluted) | $0.31 | $-0.58 | — | $0.27 | $-0.57 | $-0.65 | — | $0.90 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $114M | $67M | $57M | $80M | $131M | $146M | $183M | $180M |
| Inventory | — | $9M | $8M | $9M | $9M | $9M | $0 | $3M |
| Total current assets | $322M | $183M | $220M | $232M | $205M | $182M | $217M | $222M |
| Total assets | $345M | $218M | $257M | $271M | $245M | $225M | $262M | $264M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $303M | $197M | $201M | $204M | $199M | $145M | $146M | $144M |
| Total equity | $43M | $21M | $56M | $67M | $47M | $79M | $116M | $120M |